William Blair & Company’s Abiomed Inc ABMD Stock Holding History

William Blair & Company’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-420,582	Closed	-$103M	–	1892
2022 Q3	$103M	Buy	420,582 +3,804	+0.9%	+$1.03M	0.47%	48
2022 Q2	$103M	Sell	416,778 -25,644	-6%	-$6.92M	0.46%	50
2022 Q1	$147M	Sell	442,422 -1,303	-0.3%	-$401K	0.51%	44
2021 Q4	$159M	Buy	443,725 +11,875	+3%	+$4.01M	0.5%	45
2021 Q3	$141M	Buy	431,850 +10,521	+2%	+$3.56M	0.48%	44
2021 Q2	$132M	Buy	421,329 +17,456	+4%	+$5.36M	0.46%	48
2021 Q1	$129M	Buy	403,873 +7,891	+2%	+$2.53M	0.49%	46
2020 Q4	$128M	Sell	395,982 -4,658	-1%	-$1.29M	0.47%	50
2020 Q3	$111M	Buy	400,640 +37,541	+10%	+$10.8M	0.47%	49
2020 Q2	$87.7M	Buy	363,099 +194,637	+116%	+$39.1M	0.42%	52
2020 Q1	$24.5M	Sell	168,462 -11,093	-6%	-$1.84M	0.15%	137
2019 Q4	$30.6M	Sell	179,555 -87,714	-33%	-$16.3M	0.16%	142
2019 Q3	$47.5M	Buy	267,269 +20,264	+8%	+$4.38M	0.27%	83
2019 Q2	$64.3M	Buy	247,005 +4,419	+2%	+$1.17M	0.37%	69
2019 Q1	$69.3M	Buy	242,586 +5,244	+2%	+$1.74M	0.42%	63
2018 Q4	$77.1M	Sell	237,342 -8,756	-4%	-$3.04M	0.56%	41
2018 Q3	$111M	Sell	246,098 -10,092	-4%	-$3.98M	0.68%	34
2018 Q2	$105M	Sell	256,190 -36,765	-13%	-$13.3M	0.71%	32
2018 Q1	$85.2M	Sell	292,955 -86,931	-23%	-$22M	0.6%	40
2017 Q4	$71.2M	Sell	379,886 -19,036	-5%	-$3.55M	0.48%	51
2017 Q3	$67.3M	Sell	398,922 -3,998	-1%	-$605K	0.5%	52
2017 Q2	$57.7M	Sell	402,920 -10,090	-2%	-$1.36M	0.43%	59
2017 Q1	$50M	Buy	413,010 +18,977	+5%	+$2.2M	0.4%	65
2016 Q4	$44.4M	Buy	394,033 +7,424	+2%	+$860K	0.4%	71
2016 Q3	$49.7M	Buy	386,609 +2,614	+0.7%	+$313K	0.44%	69
2016 Q2	$42M	Buy	383,995 +178,473	+87%	+$17.8M	0.39%	74
2016 Q1	$19.5M	Sell	205,522 -20,115	-9%	-$1.7M	0.18%	137
2015 Q4	$20.4M	Sell	225,637 -24,457	-10%	-$2.08M	0.19%	135
2015 Q3	$23.2M	Sell	250,094 -849,561	-77%	-$74.9M	0.2%	130
2015 Q2	$72.3M	Sell	1,099,655 -293,110	-21%	-$19.5M	0.11%	262
2015 Q1	$99.7M	Sell	1,392,765 -483,818	-26%	-$26.3M	0.15%	195
2014 Q4	$71.4M	Sell	1,876,583 -542,702	-22%	-$17.1M	0.12%	243
2014 Q3	$60.1M	Sell	2,419,285 -232,127	-9%	-$5.88M	0.1%	272
2014 Q2	$66.7M	Sell	2,651,412 -8,000	-0.3%	-$186K	0.11%	262
2014 Q1	$69.3M	Sell	2,659,412 -13,997	-0.5%	-$387K	0.11%	250
2013 Q4	$71.5M	Buy	2,673,409 +181,635	+7%	+$4.49M	0.12%	260
2013 Q3	$47.5M	Buy	2,491,774 +254,480	+11%	+$5.82M	0.08%	340
2013 Q2	$48.2M	Buy	+2,237,294	New	+$45M	0.1%	321

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

William Blair & Company's ABMD Position: Q4 2022 in Review

William Blair & Company sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 420,582 shares — an estimated $103M sold.

William Blair & Company first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $159M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

William Blair & Company reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
William Blair & Company sold 420,582 Abiomed Inc shares in Q4 2022, an estimated $103M.
William Blair & Company first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
William Blair & Company's Abiomed Inc position peaked at $159M in Q4 2021.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on William Blair & Company's 13F filing for Q4 2022, filed 10 Feb 2023.